Advertisement

Inpharma Weekly

, Volume 1649, Issue 1, pp 21–21 | Cite as

Alprostadil [NexMed] received a non-approvable letter from the US FDA

Media release
  • 4 Downloads

Keywords

Transgenic Mouse Erectile Dysfunction Medium Release Alprostadil Carcinogenicity Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2008

Personalised recommendations